Biotechnology major Biocon has reported a 52% rise year-on-year in its net profit, which stood at ₹147 crore in the quarter ended September. Its revenue rose 21% to ₹992 crore from ₹819 crore in the year-ago period. "Our performance in Q2...was led by strong growth across small molecules, biologics, and research services,” said Chairperson and Managing Director Kiran Mazumdar-Shaw.